|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 31/435 | (2006.01) |
| A61P 25/32 | (2006.01) |
| (11) | Number of the document | 2787995 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12795315.6 |
| Date of filing the European patent application | 2012-11-29 | |
| (97) | Date of publication of the European application | 2014-10-15 |
| (45) | Date of publication and mention of the grant of the patent | 2016-08-17 |
| (46) | Date of publication of the claims translation | 2016-11-25 |
| (86) | Number | PCT/US2012/066918 |
| Date | 2012-11-29 |
| (87) | Number | WO 2013/085781 |
| Date | 2013-06-13 |
| (30) | Number | Date | Country code |
| 201161567242 P | 2011-12-06 | US |
| (72) |
KEHN, Linda Rorick, US
|
| (73) |
Eli Lilly and Company,
Lilly Corporate Center, Indianapolis, IN 46285,
US
|
| (74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (54) | Spirotienopiran-piperidino dariniai kaip ORL-1 receptoriaus antagonistai, skirti naudoti priklausomybės nuo alkoholio ir piktnaudžiavimo alkoholiu gydymui |
| SPIROTHIENOPYRAN-PIPERIDINE DERIVATIVES AS ORL-1 RECEPTOR ANTAGONISTS FOR THEIR USE IN THE TREATMENT OF ALCOHOL DEPENDENCE AND ABUSE |
| Payment date | Validity (years) | Amount | |
| 2019-10-31 | 8 | 185.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2020-11-29 |